ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,738Medicare Part D Prescriptions Filled, Including Refills

Rank: 199 out of 682

$672K Total Retail Price of All Prescriptions

Rank: 213 out of 682

347 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 347 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 10,347 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LOSARTAN POTASSIUM 575 523 1 20
LISINOPRIL 554 498 2 2
WARFARIN SODIUM 361 347 3 13
OMEPRAZOLE 333 284 4 5
POTASSIUM CHLORIDE 313 278 5 14
METOPROLOL SUCCINATE 311 291 6 16
NEXIUM 284 222 7 19
AZITHROMYCIN 277 224 8 39
LEVOTHYROXINE SODIUM 256 213 9 3
DOXAZOSIN MESYLATE 253 230 10 96
MELOXICAM 218 178 11 27
SIMVASTATIN 214 196 12 4
ALENDRONATE SODIUM 211 205 13 37
FUROSEMIDE 203 196 14 7
METFORMIN HCL 186 149 15 8
AMLODIPINE BESYLATE 169 167 16 6
ALLOPURINOL 165 165 17 32
DIOVAN 140 127 18 42
CLOPIDOGREL 137 134 19 25
SYMBICORT 133 92 20 117
TRAMADOL HCL 131 87 21 26
CARVEDILOL 125 122 22 23
CRESTOR 123 90 23 22
ATORVASTATIN CALCIUM 114 111 24 11
BUMETANIDE 112 100 25 115
GABAPENTIN 111 98 26 9
SINGULAIR 110 87 27 63
ZOLPIDEM TARTRATE 108 104 28 21
METOPROLOL TARTRATE 104 98 29 10
AMLODIPINE BESYLATE-BENAZEPRIL 98 81 30 77
DIGOXIN 93 93 31 46
ISOSORBIDE MONONITRATE ER 92 92 32 31
FLUTICASONE PROPIONATE 85 74 33 36
SYNTHROID 84 84 34 59
PLAVIX 84 79 34 35
TAMSULOSIN HCL 84 82 34 33
LEVOFLOXACIN 77 61 37 70
ATENOLOL 76 76 38 18
METHYLPREDNISOLONE 76 53 38 127
AMILORIDE-HYDROCHLOROTHIAZIDE 75 69 40 354
GLIPIZIDE 74 54 41 61
AMITRIPTYLINE HCL 74 65 R 41 50
DOXYCYCLINE HYCLATE 72 64 43 137
NIFEDIPINE ER 72 72 43 144
SERTRALINE HCL 72 61 43 24
PROAIR HFA 71 55 46 45
METHOCARBAMOL 70 39 R 47 163
HYDROCHLOROTHIAZIDE 70 70 47 12
GLYBURIDE 67 64 R 49 72
LOVASTATIN 66 52 50 66
ONGLYZA 66 66 50 219
PANTOPRAZOLE SODIUM 64 41 52 29
CITALOPRAM HBR 64 52 52 17
NASONEX 63 55 54 199
IRBESARTAN 63 63 54 234
SOTALOL 61 61 56 218
TRIAMTERENE-HCTZ 60 56 57 57
MONTELUKAST SODIUM 60 48 57 112
RAMIPRIL 58 46 59 81
FINASTERIDE 57 57 60 131
CIPROFLOXACIN HCL 55 53 61 58
MECLIZINE HCL 54 54 62 124
PRAVASTATIN SODIUM 53 26 63 15
ATACAND 50 44 64 363
CLONIDINE HCL 50 41 64 48
TERAZOSIN HCL 50 43 64 171
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.